tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
AML, Acute Myeloid Leukemia: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
toxicity↝, tumCV↓, ROS↑, p38↑, NRF2↓, NF-kB↝, DNAdam↑, Apoptosis↑,
| - |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
THP1 |
|
|
|
Apoptosis↑, Casp7↑, PARP1↑, Bcl-2↓, Myc↓, CHOP/DDIT3↑, P21↑, p62↑, TumCCA↑, TXNIP↑, ROS↑, *antiOx↑, *Inflam↓, *neuroP↑, AntiCan↑, TumCP↓, angioG↓, TumMeta↓, VEGF↓, MMPs↓, tumCV↓, DNAdam↑, CHOP/DDIT3↑, cMyc↓, BioAv↓, Half-Life↓, BioAv↑,
compI↓, tumCV↓, SOD2↑, MMP↓, Ca+2↝, Casp3↑, Casp9↑,
SUV39H↓, Apoptosis↑, ROS↑, TumCCA↑, tumCV↓, Casp3↑, Casp9↑, Fas↑, FasL↑, DR4↑, P21↑, eff↓, eff↑,
tumCV↓, ROS↑, antiOx↓, MMP↓, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, *neuroP↑, AntiCan↑, *AntiArt↑, TBARS↑, SOD↓, GSH↓, Catalase↓,
| - |
in-vitro, |
lymphoma, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
Jurkat |
|
|
|
TumCP↓, selectivity↑, Apoptosis↑, TumCCA↑, DNAdam↑, eff↓, ROS↑, tumCV↓,
| - |
in-vitro, |
AML, |
MV411 |
|
|
|
- |
in-vitro, |
AML, |
HL-60 |
|
|
|
Apoptosis↑, TumAuto↑, *toxicity↓, selectivity↑, Casp8↑, MMP↓, *Inflam↓, *antiOx↑, *AntiCan↑, DNAdam↑, cl‑Casp3↑, tumCV↓, ROS↑,
ROS↑, mt-Apoptosis↑, TumCCA↑, PI3K↓, Akt↓, STAT3↓, Dose↝, *hepatoP↑, Casp8↑, mtDam↑, TumCD↑, selectivity↑, DNAdam↑, BAX↑, P53↑, Bcl-2↓, CSCs↓, *toxicity↓, tumCV↓, Imm↑, FAK↓, mTOR↓, ChemoSen↑, eff↝, eff↑,
tumCV↓, TumCP↓, selectivity↑, NF-kB↓, IKKα↓, MAPK↓,
tumCV↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Cyt‑c↑, cl‑PARP↓, DNAdam↑, Casp3↑, FASN↓, Casp8↑,
tumCV↓, DNAdam↑, RB1↓, Bcl-2↓, BAX↑,
| - |
in-vitro, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
AML, |
U937 |
|
|
|
- |
in-vitro, |
AML, |
SK-HEP-1 |
|
|
|
tumCV↓, TumCCA↑, Ferroptosis↑, lipid-P↑, HO-1↑, GPx4∅,
Apoptosis↑, Diff↑, tumCV↓, TumCP↓, MMP↓, BAX↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, Cyt‑c↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, p‑MEK↑, p‑ERK↑, ROS↑, eff↓,
selectivity↑, LC3I↑, LC3II↑, Beclin-1/ATG6↑, ROS↑, tumCV↓, Dose↝, TumAuto↑,
| - |
in-vitro, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
AML, |
Jurkat |
|
|
|
- |
in-vitro, |
AML, |
HL-60 |
|
|
|
tumCV↓, Casp3↑, Casp8↑, Casp9↑, P53↑, BAX↑, Fas↑, FasL↑, MAPK↑, NRF2↓, GSH↓,
tumCV↓, Apoptosis↑, ROS↑, eff↓, DR4↑, DR5↑, TRAIL↑,
Prx↓, AQPs↓, NOX↓, tumCV↓, AntiCan↑, cardioP↑, neuroP↑, Inflam↓, chemoPv↑, angioG↓, TumMeta↓, selectivity↑, ROS↓,
eff↑, tumCV↓, TumCCA↑, ROS↑, MMP↓, eff↑, TumVol↓, eff↑, Ki-67↓,
| - |
in-vitro, |
AML, |
K562 |
|
|
|
- |
in-vitro, |
lymphoma, |
U937 |
|
|
|
tumCV↓, Dose↝,
tumCV↓, selectivity↑, Apoptosis↑, eff↑, ChemoSen↑,
tumCV↓, toxicity↓, selectivity↑, Apoptosis↑, Hif1a↓, Casp3↑, eff↑,
Showing Research Papers: 1 to 21 of 21
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 21
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
SUV39H↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, Catalase↓, 1, compI↓, 1, Ferroptosis↑, 1, GPx4∅, 1, GSH↓, 2, HO-1↑, 1, lipid-P↑, 1, NRF2↓, 2, Prx↓, 1, ROS↓, 1, ROS↑, 11, SOD↓, 1, SOD2↑, 1, TBARS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
p‑MEK↑, 1, MMP↓, 5, mtDam↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1, FASN↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 10, mt-Apoptosis↑, 1, BAX↑, 4, Bax:Bcl2↑, 1, Bcl-2↓, 4, Bcl-xL↓, 1, Casp3↑, 6, cl‑Casp3↑, 2, Casp7↑, 1, Casp8↑, 5, Casp9↑, 4, cl‑Casp9↑, 1, Cyt‑c↑, 2, DR4↑, 2, DR5↑, 1, Fas↑, 2, FasL↑, 2, Ferroptosis↑, 1, MAPK↓, 1, MAPK↑, 1, Mcl-1↓, 1, Myc↓, 1, p27/CDKN1B↑, 1, p38↑, 1, TRAIL↑, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 21,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 2,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1/ATG6↑, 1, LC3I↑, 1, LC3II↑, 1, p62↑, 1, TumAuto↑, 2,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 7, P53↑, 2, cl‑PARP↓, 1, cl‑PARP↑, 1, PARP1↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, cycE/CCNE↓, 1, P21↑, 3, RB1↓, 1, TumCCA↑, 7,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, Diff↑, 1, p‑ERK↑, 1, mTOR↓, 1, PI3K↓, 1, STAT3↓, 1,
Migration(tgid=13) ⓘ
Ca+2↝, 1, FAK↓, 1, Ki-67↓, 1, MMPs↓, 1, TumCP↓, 4, TumMeta↓, 2, TXNIP↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 2, Hif1a↓, 1, VEGF↓, 1,
Barriers & Transport(tgid=15) ⓘ
AQPs↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IKKα↓, 1, Imm↑, 1, Inflam↓, 1, NF-kB↓, 1, NF-kB↝, 1,
Cellular Microenvironment(tgid=17) ⓘ
NOX↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 2, Dose↝, 3, eff↓, 4, eff↑, 7, eff↝, 1, Half-Life↓, 1, selectivity↑, 8,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 1, Myc↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 3, cardioP↑, 1, chemoPv↑, 1, neuroP↑, 1, toxicity↓, 1, toxicity↝, 1, TumVol↓, 1,
Total Targets: 106
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiArt↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 2,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, hepatoP↑, 1, neuroP↑, 2, toxicity↓, 2,
Total Targets: 7
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page